Press release
Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) over possible Wrongdoing
An investigation on behalf of current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: MGX stocks follows a lawsuit filed against Metagenomi, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: MGX stocks, concerns whether certain Metagenomi, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Northern District of California the plaintiff alleges that, the Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. The action seeks to compensate the Class members and recover the damages they sustained because of Defendants' allegedly false and misleading statements.
Those who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) over possible Wrongdoing here
News-ID: 3928112 • Views: …
More Releases from Shareholders Foundation, Inc.
Investigation announced for Long-Term Investors in shares of Organon & Co. (NYSE …
An investigation was announced for current long-term investors in shares of Organon & Co. (NYSE: OGN) concerning potential breaches of fiduciary duties by certain directors of Organon & Co.
Investors who are current long term investors in Organon & Co. (NYSE: OGN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors…
Lawsuit filed for Investors who lost money with shares of Charter Communications …
An investor, who purchased shares of Charter Communications, Inc. (NASDAQ: CHTR), filed a lawsuit over alleged violations of Federal Securities Laws by Charter Communications, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Charter Communications, Inc. (NASDAQ: CHTR) have certain options and for certain investors are short and strict deadlines running. Deadline: October 14, 2025. NASDAQ: CHTR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Investigation announced for Investors in Vestis Corporation (NYSE: VSTS) over po …
An investigation was announced for current long-term investors in shares of Vestis Corporation (NYSE: VSTS) concerning potential breaches of fiduciary duties by certain directors of Vestis Corporation.
Investors who are current long term investors in Vestis Corporation (NYSE: VSTS) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: VSTS…
iRobot Corporation (NASDAQ: IRBT) Investor Alert: Deadline in Lawsuit on Septemb …
A deadline is coming up on September 5, 2025 in the lawsuit filed for certain investors of iRobot Corporation (NASDAQ: IRBT) over alleged securities laws violations by iRobot Corporation.
Investors who purchased shares of iRobot Corporation (NASDAQ: IRBT) have certain options and there are strict and short deadlines running. Deadline: September 5, 2025. iRobot Corporation (NASDAQ: IRBT) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According…
More Releases for Metagenomi
Long Term Investors in shares of Metagenomi, Inc. (NASDAQ: MGX) should contact t …
An investigation on behalf of current long-term investors in shares of Metagenomi, Inc. (NASDAQ: MGX) concerning potential breaches of fiduciary duties by certain directors and officers of Metagenomi, Inc. was announced.
Investors who are current long term investors in Metagenomi, Inc. (NASDAQ: MGX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Trump's "Stargate AI" Healthcare/Medical Watch: CSDX, IPA, MGX, CDIO
In a world where healthcare innovation is accelerating, companies leveraging artificial intelligence are leading the charge in transforming patient care, diagnostics, and therapeutic solutions. Their advancements in smart disinfection, AI-designed therapies, precision gene editing, and cardiovascular diagnostics are not only reshaping their industries but also unlocking tremendous growth potential. Here's how these cutting-edge companies are redefining the future of healthcare.
CS Diagnostics Corp. (OTCQB: CSDX) Launches Next-Gen Disinfectant MEDUSA a cutting-edge…
Lawsuit filed for Investors who lost money with shares of Metagenomi, Inc. (NASD …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX) have certain options and for certain investors are short and strict deadlines running. Deadline: November 25, 2024. NASDAQ: MGX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)…
Lawsuit filed for Investors who lost money with Metagenomi, Inc. (NASDAQ: MGX) i …
An investor, who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), filed a lawsuit over alleged violations of Federal Securities Laws by Metagenomi, Inc. in connection with certain allegedly false and misleading statements made between February 9 and 13, 2024.
Investors who purchased a significant amount of shares of Metagenomi, Inc. (NASDAQ: MGX) between February 9 and 13, 2024, have certain options and for certain investors are short and strict deadlines running.…
Investigation announced for Investors in shares of Metagenomi, Inc. (NASDAQ: MGX …
An investigation was announced for investors of Metagenomi, Inc. (NASDAQ: MGX) shares over potential securities laws violations by Metagenomi, Inc.
Investors who purchased shares of Metagenomi, Inc. (NASDAQ: MGX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Metagenomi, Inc. (NASDAQ: MGX) concerning whether a series…
U.S. GENE EDITING MARKET IS EXPECTED TO REACH USD 9.16 BILLION BY 2027 - ARIZTON
Genome editing aims to modify the DNA sequence so cells can make the correct protein again. NIH created the SCGE program in January 2018 to improve genome editing technology and make genome editing therapies more widely available. Genome editing has a great potential to change the treatment environment for both common and rare diseases. Gene editing is in its infancy, and these newly funded projects promise better strategies to address…
